Complex modulation of cell type-specific signaling in response to type I interferons
- PMID: 16979568
- DOI: 10.1016/j.immuni.2006.08.014
Complex modulation of cell type-specific signaling in response to type I interferons
Abstract
The type I interferons (IFNs) are pleiotropic cytokines that regulate many different cellular functions. The major signaling pathway activated by type I IFNs involves sequential phosphorylation of the tyrosine residues of the Janus kinase (JAK) and signal transducers and activators of transcription (STAT) proteins, providing the primary mechanism through which gene expression is induced. Recent work has shown that the responses are quite complex, as shown by different responses to specific subtypes of type I IFN, activation of kinases in addition to JAKs, patterns of activation of all seven STATs in different cells, and activation of transcription factors other than STATs. The type I IFNs use this complexity to regulate many different biological functions in different types of cells, by activating different specific signals and patterns of gene expression.
Similar articles
-
Mechanisms of type I interferon signaling in normal and malignant cells.Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):156-63. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15247882 Review.
-
STAT activation and differential complex formation dictate selectivity of interferon responses.Acta Biochim Pol. 2007;54(1):27-38. Epub 2007 Mar 9. Acta Biochim Pol. 2007. PMID: 17351669 Review.
-
JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases.Vascul Pharmacol. 2005 Nov;43(5):357-63. doi: 10.1016/j.vph.2005.08.021. Epub 2005 Nov 3. Vascul Pharmacol. 2005. PMID: 16271517 Review.
-
Janus tyrosine kinases and signal transducers and activators of transcription regulate critical functions of T cells in allograft rejection and transplantation tolerance.Transplantation. 2006 Aug 15;82(3):295-303. doi: 10.1097/01.tp.0000228903.03118.be. Transplantation. 2006. PMID: 16906023 Review.
-
Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.Mt Sinai J Med. 2002 May;69(3):156-68. Mt Sinai J Med. 2002. PMID: 12035075 Review.
Cited by
-
NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes.PLoS One. 2016 May 4;11(5):e0154674. doi: 10.1371/journal.pone.0154674. eCollection 2016. PLoS One. 2016. PMID: 27144453 Free PMC article.
-
Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.Am J Pathol. 2012 Jul;181(1):151-62. doi: 10.1016/j.ajpath.2012.03.023. Epub 2012 May 22. Am J Pathol. 2012. PMID: 22626807 Free PMC article.
-
A STATus report on DC development.J Leukoc Biol. 2012 Sep;92(3):445-59. doi: 10.1189/jlb.0212052. Epub 2012 May 1. J Leukoc Biol. 2012. PMID: 22550127 Free PMC article. Review.
-
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.Front Immunol. 2012 Apr 9;3:67. doi: 10.3389/fimmu.2012.00067. eCollection 2012. Front Immunol. 2012. PMID: 22566948 Free PMC article.
-
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.Pigment Cell Melanoma Res. 2021 Jul;34(4):683-695. doi: 10.1111/pcmr.12935. Epub 2020 Oct 26. Pigment Cell Melanoma Res. 2021. PMID: 33040466 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources